ArticleCancers2024
Nivolumab as Second-Line Therapy Improves Survival in Patients with Unresectable Hepatocellular Carcinoma.
Faisal M Sanai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCancers2024
Faisal M Sanai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.